Uniphar plc, a leading healthcare services provider, is headquartered in Dublin, Ireland, with significant operations across the UK and Europe. Founded in 1998, the company has established itself within the pharmaceutical and healthcare industry, focusing on three main business areas: Commercial & Clinical, Supply Chain, and Retail. Uniphar's core offerings include innovative distribution solutions, clinical trial management, and pharmacy services, all designed to enhance patient outcomes and streamline healthcare delivery. The company is recognised for its unique approach to integrating technology with traditional healthcare services, positioning it as a key player in the market. With a commitment to excellence, Uniphar has achieved notable milestones, including strategic partnerships and expansions that reinforce its reputation as a trusted provider in the healthcare sector.
How does Uniphar's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Uniphar's score of 33 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Uniphar reported total greenhouse gas emissions of approximately 5.9 million tonnes CO2e, comprising about 2.98 million tonnes from Scope 1 and approximately 2.92 million tonnes from Scope 2 emissions. This reflects a commitment to reducing their carbon footprint significantly. Uniphar has set ambitious targets to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50% by 2030, using 2019 as the baseline year. Additionally, the company aims for 73.5% of its suppliers, based on emissions from purchased goods and services, to have science-based targets by 2027. Over the years, Uniphar has demonstrated a consistent effort to lower emissions, with total Scope 1 and 2 emissions decreasing from about 7.75 million tonnes CO2e in 2018 to approximately 5.9 million tonnes CO2e in 2023. This reduction aligns with industry standards and reflects Uniphar's commitment to sustainability within the healthcare sector. Overall, Uniphar's climate commitments and reduction initiatives position the company as a proactive participant in addressing climate change, aiming for substantial progress in the coming years.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Scope 1 | 3,954,880 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 3,794,840 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Uniphar is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.